文献速递中医内科中药与中成药合理使用

化湿通痹方治疗湿热困脾型勃起功能障碍的多中心随机对照非劣效性试验

Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial.
PubMed 文献 · Chin J Integr Med · 2025-09-12

本研究为多中心随机对照非劣效性试验,纳入162例湿热困脾型勃起功能障碍患者,按2:1随机分为化湿通痹方组(108例)和枸橼酸西地那非组(54例),治疗8周并随访8周。结果显示化湿通痹方疗效非劣于西地那非,且在改善中医证候和停药后疗效持久性方面有优势,可能通过调节肠道菌群发挥作用。

要点

  • 化湿通痹方治疗湿热困脾型ED的8周有效率非劣于西地那非。
  • 化湿通痹方在改善中医证候和停药后疗效维持方面优于西地那非。
  • 化湿通痹方可能通过调节肠道菌群(如增加Lachnospiraceae和Blautia)发挥作用。

核心结论

  • 化湿通痹方治疗湿热困脾型勃起功能障碍的疗效非劣于西地那非,且具有缓解整体症状和停药后疗效稳定持久的优势,可能通过调节肠道菌群介导。

研究设计与样本

  • 多中心、随机、平行、阳性对照、非劣效性试验,共纳入162例湿热困脾型ED患者,按2:1随机分为治疗组108例和对照组54例。
  • 治疗组给予化湿通痹方颗粒(每次1袋,每日2次),对照组按需口服枸橼酸西地那非片50 mg,均治疗8周并随访8周。

主要发现

  • 意向性分析(ITT)和符合方案集分析(PP)显示,治疗8周后两组有效率差值及95%CI分别为-3.7%(-17.9%,10.5%)和-4.5%(-18.2%,9.2%)。
  • 治疗2周时治疗组IIEF-5和EQS评分低于对照组而CMS评分高于对照组(P<0.05);4周时IIEF-5仍较低(P<0.05);6周时所有评分组间相似(P>0.05);8周时CMS评分低于对照组(P<0.05)。
  • 随访4周和8周时,治疗组IIEF-5和EQS评分高于对照组,CMS评分低于对照组(P<0.05);两组所有评分较基线均显著改善(P<0.05)。
  • 两组安全指标无显著差异(P>0.05);化湿通痹方治疗后Lachnospiraceae和Blautia相对丰度增加,Levilactobacillus和Lactiplantibacillus丰度增加,Bilophila、Saccharimonadia、Patescibacteria等丰度降低(线性判别分析评分>2)。
  • 化湿通痹方组9种肠道菌群预测功能(包括氨基酸相关酶、外泌体、线粒体生物发生等)降低,而蛋白激酶功能增加(P<0.05)。

关键数值与推荐

  • 主要指标为治疗8周后的有效率,采用ITT和PP分析,非劣效性界值未在摘要中报告。
  • 次要指标包括IIEF-5评分、EQS和中医证候评分,治疗期间每2周分析一次,随访期间每4周分析一次。

临床怎么用

  • 化湿通痹方可作为湿热困脾型勃起功能障碍的替代治疗选择,尤其适用于希望改善整体症状和停药后疗效持久的患者。
  • 临床决策时可参考化湿通痹方与西地那非疗效非劣的结果,结合患者证候和偏好个体化选用。

局限性

  • 摘要未报告非劣效性界值、样本量估算依据及具体不良反应事件细节。
  • 随访时间较短(8周),长期疗效和安全性需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect and safety of Chinese herbal compound Huashi Tongbi Formula (HTF) for the treatment of erectile dysfunction (ED) with damp heat affecting Pi (Spleen) pattern, and explore the possible mechanisms based on the analysis of gut microbiota. METHODS: In this multicentre, randomized, parallel, positive control, noninferiority trial, a total of 162 ED patients with damp heat affecting Pi pattern were randomly divided into a treatment group (108 patients) and a control group (54 patients) in a 2:1 ratio using a random number table method. The treatment group was administered HTF granules (1 bag each time, twice a day). The control group was given sildenafil citrate tablets (50 mg, orally as needed). Both groups were treated for 8 weeks with a 8-week followed-up period. The main indicator was effective rate after 8-week treatment analysed using intention-to-treat (ITT) and per-protocol (PP) methods, and the secondary indicators included International Index of Erectile Function-5 (IIEF-5) score, Erectile Quality Score (EQS), and Chinese medicine syndrome (CMS) score, which were analysed using ITT every 2 weeks during 8-week treatment period, and every 4 weeks during 8-week follow-up period. The 16S rDNA sequencing was used to analyse the impact of HTF on the gut microbiota. The adverse events (AEs) and changes in safety indicators of the two groups were recorded. RESULTS: A total of 162 patients were included in the ITT analysis, with 23 patients dropping out during the trial period (12 in the treatment group and 11 in the control group), and 139 patients were included in the PP analysis. ITT and PP analyses revealed that after 8-week treatment the difference and 95% confidence intervals (CIs) in the effective rates between the treatment and the control groups were -3.7% (-17.9%, 10.5%) and -4.5% (-18.2%, 9.2%), respectively. At 2 weeks of treatment, the treatment group showed lower IIEF-5 and EQS scores but higher CMS score vs. control (P<0.05); at 4 weeks, IIEF-5 remained lower (P<0.05), while EQS and CMS scores were comparable (P>0.05); by 6 weeks, all scores (IIEF-5, EQS, CMS) were similar between groups (P>0.05); at 8 weeks, IIEF-5 and EQS were comparable, but CMS scores were lower (P<0.05). During 4- and 8-week follow-up, the treatment group had higher IIEF-5 and EQS scores and lower CMS scores (P<0.05). Both groups showed significant improvements in all scores from baseline (P<0.05). There was no significant difference in the safety indicators between groups (P>0.05). After HTF treatment, the relative abundances of Lachnospiraceae and Blautia increased, contributing the most to the differences in the microbial communities between groups. The abundances of Levilactobacillus and Lactiplantibacillus increased, whereas the abundances of Bilophila, Saccharimonadia, Patescibacteria, and others decreased in the treatment group (linear discriminant analysis score>2). Nine predictive functions of the gut microbiota including amino acid related enzymes, exosome, mitochondrial biogenesis, etc. were reduced, whereas protein kinase function increased in the treatment group (P<0.05). CONCLUSION: HTF showed noninferior efficacy to sildenafil for ED with damp heat affecting Pi pattern, with the advantages of relieving overall symptoms and stable and lasting therapeutic effect after discontinuation, potentially mediated by gut microbiota modulation. (Registration No. ChiCTR2300067825).

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Zou HD, Zhang PH, Chen WK, et al. Effect of Huashi Tongbi Formula on Erectile Dysfunction with Damp Heat Affecting Pi (Spleen) Pattern: A Multicentre, Randomized, Controlled Noninferiority Trial. Chin J Integr Med. 2025. PMID: 40938504. doi:10.1007/s11655-025-4142-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。